BRPI0515849A - dispositivos e métodos para fabricação integrada contìnua de moléculas biológicas - Google Patents

dispositivos e métodos para fabricação integrada contìnua de moléculas biológicas

Info

Publication number
BRPI0515849A
BRPI0515849A BRPI0515849-4A BRPI0515849A BRPI0515849A BR PI0515849 A BRPI0515849 A BR PI0515849A BR PI0515849 A BRPI0515849 A BR PI0515849A BR PI0515849 A BRPI0515849 A BR PI0515849A
Authority
BR
Brazil
Prior art keywords
continuous
methods
devices
biological molecules
integrated
Prior art date
Application number
BRPI0515849-4A
Other languages
English (en)
Inventor
Jens Holger Vogel
Roberto Giovannini
Konstantin B Konstantinov
Huong My Nguyen
Paul Wu
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36143124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0515849(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of BRPI0515849A publication Critical patent/BRPI0515849A/pt
Publication of BRPI0515849B1 publication Critical patent/BRPI0515849B1/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/24—Apparatus for enzymology or microbiology tube or bottle type
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/14—Pressure control
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/16—Flow or flux control
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2313/00—Details relating to membrane modules or apparatus
    • B01D2313/10—Specific supply elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2313/00—Details relating to membrane modules or apparatus
    • B01D2313/10—Specific supply elements
    • B01D2313/105—Supply manifolds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2313/00—Details relating to membrane modules or apparatus
    • B01D2313/18—Specific valves
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2317/00—Membrane module arrangements within a plant or an apparatus
    • B01D2317/04—Elements in parallel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Filtration Of Liquid (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"DISPOSITIVOS E MéTODOS PARA FABRICAçãO INTEGRADA CONTìNUA DE MOLéCULAS BIOLóGICAS". Esta invenção se refere a um processo e um aparelho para purificar uma molécula de interesse proveniente de uma mistura fluida clarificada heterogênea. O aparelho da invenção geralmente consiste em um sistema de fermentação de perfusão contínua, um sistema de remoção contínua de partículas integrado ao sistema de fermentação de perfusão; e um sistema de purificação contínua integrado ao sistema de remoção de partículas, que é mantido sob condições estéreis. O processo consiste na filtração de uma mistura fluida clarificada e heterogênea pela ultrafiltração contínua a uma taxa de fluxo específica abaixo do ponto de transição da molécula de interesse na região de fluxo que depende da pressão em relação à curva TMP, em que a taxa de fluxo específica é mantida consideravelmente constante durante toda ultrafiltração contínua.
BRPI0515849-4A 2004-09-30 2005-09-30 Processo para purificar uma proteína de interesse proveniente de uma mistura fluida de cultura de tecido heterogênea e aparelho para separar uma proteína de interesse da mistura fluida de cultura de tecido heterogênea BRPI0515849B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61499504P 2004-09-30 2004-09-30
US60/614.995 2004-09-30
PCT/US2005/035364 WO2006039588A2 (en) 2004-09-30 2005-09-30 Devices and methods for integrated continuous manufacturing of biological molecules

Publications (2)

Publication Number Publication Date
BRPI0515849A true BRPI0515849A (pt) 2008-08-12
BRPI0515849B1 BRPI0515849B1 (pt) 2019-07-30

Family

ID=36143124

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515849-4A BRPI0515849B1 (pt) 2004-09-30 2005-09-30 Processo para purificar uma proteína de interesse proveniente de uma mistura fluida de cultura de tecido heterogênea e aparelho para separar uma proteína de interesse da mistura fluida de cultura de tecido heterogênea

Country Status (24)

Country Link
US (3) US9045725B2 (pt)
EP (2) EP2550971B1 (pt)
JP (2) JP5579966B2 (pt)
KR (2) KR101238798B1 (pt)
CN (2) CN102794109B (pt)
AU (1) AU2005292358B2 (pt)
BR (1) BRPI0515849B1 (pt)
CA (1) CA2579845C (pt)
CY (1) CY1117699T1 (pt)
DK (2) DK2550971T3 (pt)
ES (2) ES2570006T3 (pt)
HR (1) HRP20070097B1 (pt)
HU (2) HUE032538T2 (pt)
IL (5) IL181775A (pt)
LT (1) LT2550971T (pt)
NO (2) NO341439B1 (pt)
NZ (2) NZ588616A (pt)
PL (1) PL1807101T3 (pt)
PT (1) PT2550971T (pt)
RU (1) RU2390526C2 (pt)
SI (1) SI2550971T1 (pt)
UA (3) UA112529C2 (pt)
WO (1) WO2006039588A2 (pt)
ZA (1) ZA200702578B (pt)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1807101T3 (pl) 2004-09-30 2016-11-30 Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
BRPI0920572A8 (pt) 2008-10-20 2015-10-27 Abbott Lab Inativação viral durante a purificação dos anticorpos
US9527010B2 (en) 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
JP5860887B2 (ja) 2010-10-15 2016-02-16 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 大容量使い捨て限外濾過システム及び方法
CN102154408B (zh) * 2011-01-13 2013-06-05 天津市工业微生物研究所 小核菌硬葡聚糖在线发酵提取方法及系统
US9982227B2 (en) 2011-03-08 2018-05-29 University Of Maryland, Baltimore County System and method for production of on-demand proteins in a portable unit for point of care delivery
US10774304B2 (en) * 2011-03-08 2020-09-15 University Of Maryland, Baltimore County System and method for production of on-demand proteins in a portable unit for point of care delivery
US12227734B2 (en) 2011-03-08 2025-02-18 University Of Maryland, Baltimore County Microscale bioprocessing system and method for protein manufacturing from human blood
US9388373B2 (en) * 2011-03-08 2016-07-12 University Of Maryland Baltimore County Microscale bioprocessing system and method for protein manufacturing
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CA2852052C (en) * 2011-10-11 2017-01-17 Sentry Depressurization Systems, Inc. Depressurization system for an electrical transformer
CA2861270C (en) 2012-01-18 2021-08-03 Bayer Healthcare Llc Perfusion bioreactor systems comprising a cell aggregate trap and methods of operating the same
US9997264B2 (en) * 2012-02-14 2018-06-12 Control Components, Inc. Enhanced nuclear sump strainer system
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
SG10201806083RA (en) 2013-02-22 2018-08-30 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof
HUE042094T2 (hu) 2013-02-22 2019-06-28 Genzyme Corp Mikrokarrier-perfúziós tenyésztési eljárások és alkalmazásuk
AU2014226126B2 (en) 2013-03-08 2019-02-14 Genzyme Corporation Continuous purification of therapeutic proteins
HK1207960A1 (en) 2013-03-12 2016-02-19 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
US20170058308A1 (en) * 2014-05-02 2017-03-02 Novo Nordisk A/S Integrated continuous biomanufacturing process
EP4218991A1 (en) 2014-05-13 2023-08-02 Amgen Inc. Process control systems and methods for use with filters and filtration processes
AU2015267312B2 (en) * 2014-05-27 2018-06-28 Artificial Cell Technologies, Inc. Automated layer by layer construction of multilayer coated cores by TFF
TWI743024B (zh) 2014-06-06 2021-10-21 美商健臻公司 灌注培養方法及其用途
TWI707949B (zh) 2014-06-09 2020-10-21 美商健臻公司 種子罐培養法（ｓｅｅｄ ｔｒａｉｎ ｐｒｏｃｅｓｓｅｓ）及其用途
WO2015195453A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Methods for increasing the capacity of flow-through processes
US10207225B2 (en) 2014-06-16 2019-02-19 Emd Millipore Corporation Single-pass filtration systems and processes
ES2742704T3 (es) 2014-06-25 2020-02-17 Emd Millipore Corp Elementos, módulos y sistemas de filtro compactos, enrollados en espiral
SG11201508664VA (en) 2014-08-29 2016-03-30 Emd Millipore Corp Single Pass Tangential Flow Filtration Systems and Tangential Flow Filtration Systems withRecirculation of Retentate
CN108325391B (zh) 2014-08-29 2021-05-18 Emd 密理博公司 过滤液体进料的方法
USD761381S1 (en) 2014-12-18 2016-07-12 Emd Millipore Corporation Retentate plate
USD762811S1 (en) 2014-12-18 2016-08-02 Emd Millipore Corporation Diverter plate
EP3093335A1 (de) 2015-05-13 2016-11-16 Bayer Technology Services GmbH Prozessleitsystem zur regelung und steuerung einer modular aufgebauten anlage zur produktion von biopharmazeutischen und biologischen makromolekularen produkten
ITUA20161506A1 (it) * 2016-03-09 2017-09-09 Della Toffola Spa Metodo ed impianto perfezionato di filtrazione tangenziale
US20200289987A1 (en) 2016-03-14 2020-09-17 Pendotech Processing System for Multiple Tangential Flow Filtration Stations in Bioprocessing Applications
CA3023486C (en) 2016-06-09 2022-03-29 Emd Millipore Corporation Radial-path filter elements, systems and methods of using same
CN109475868B (zh) * 2016-07-21 2021-08-17 新加坡科技研究局 用于高体积分数颗粒微滤的外壁聚焦的设备及其制造方法
KR20190079662A (ko) * 2016-11-11 2019-07-05 바이엘 악티엔게젤샤프트 연속적 유동 내의 오염물을 모니터링하기 위한 유체 스트림의 샘플링 방법
EP3141594A3 (en) * 2016-11-11 2017-06-14 Bayer Pharma Aktiengesellschaft Method for sampling fluid streams for monitoring contaminants in a continuous flow
EP3535047A1 (en) * 2016-12-09 2019-09-11 Lonza Ltd Method for the reduction of viral titer in pharmaceuticals
EP3354330A1 (en) 2017-01-25 2018-08-01 Sartorius Stedim Biotech GmbH Automated modular filtration system
CA2994643A1 (en) * 2017-02-14 2018-08-14 Bart Lipkens Bioreactor using acoustic standing waves
CN110268043A (zh) 2017-03-03 2019-09-20 富士胶片株式会社 细胞培养装置及细胞培养方法
JP2018153168A (ja) * 2017-03-21 2018-10-04 国立大学法人九州大学 微生物収集装置
DE102017110482A1 (de) * 2017-05-15 2018-11-15 Sartorius Stedim Biotech Gmbh Filtrationsmodul bzw. Reinigungsmodul für modulares Filtrationssystem
DE102017111133A1 (de) * 2017-05-22 2018-11-22 Sartorius Stedim Biotech Gmbh Vorkonfigurierte Einweg-Filtrationsvorrichtung
TWI675696B (zh) * 2017-06-01 2019-11-01 美商Ｅｍｄ密理博公司 用於灌注應用之切向流過濾裝置
US11364469B2 (en) 2017-06-20 2022-06-21 Asahi Kasei Kabushiki Kaisha Hollow fiber membrane module and filtering method
TWI846694B (zh) * 2018-05-04 2024-07-01 美商健臻公司 具有過濾系統的灌注式生物反應器
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
GB201810772D0 (en) * 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
AU2019332764B2 (en) 2018-08-31 2025-05-29 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
GB201816871D0 (en) * 2018-10-17 2018-11-28 Ge Healthcare Bio Sciences Ab A bioprocessing fluid sensor arrangement
DE102019100209A1 (de) 2019-01-07 2020-07-09 Sartorius Stedim Biotech Gmbh Vorrichtung und Verfahren zum Ausgleich von kurzfristigen Druck- oder Volumenschwankungen eines Mediums in einem kontinuierlich geführten biopharmazeutischen Prozess
JP2022520793A (ja) * 2019-02-15 2022-04-01 ジャスト－エヴォテック バイオロジックス、インコーポレイテッド 自動バイオ製造システム、施設、及びプロセス
CN111018968B (zh) * 2019-12-16 2021-07-27 兴盟生物医药(苏州)有限公司 一种通过超滤浓缩制备高浓度抗体制剂的方法
US12050448B2 (en) 2021-01-29 2024-07-30 Tata Consultancy Services Limited Method and system to control a continuous bioprocessing
GB202109015D0 (en) * 2021-06-23 2021-08-04 Puridify Ltd A method for purifying a feed in a chromatography system
JPWO2023191008A1 (pt) * 2022-03-30 2023-10-05
EP4501335A4 (en) * 2022-03-30 2025-07-23 Fujifilm Corp METHOD FOR PRODUCING ACTIVE INGREDIENT OF BIOLOGICAL DRUG, SYSTEM FOR PRODUCING ACTIVE INGREDIENT OF BIOLOGICAL DRUG, AND ACTIVE INGREDIENT OF BIOLOGICAL DRUG
EP4594462A1 (en) * 2022-09-28 2025-08-06 Genzyme Corporation Systems and devices for producing biological products and methods of using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157113A (en) * 1987-08-10 1992-10-20 Miles Inc. Removal of nucleic acids from monoclonal antibody preparations
US5256294A (en) * 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
US5463029A (en) * 1992-11-23 1995-10-31 Immunex Corporation Purification of fusion proteins comprising GM-CSF and IL-3
ATE328068T1 (de) * 1994-05-16 2006-06-15 Merck & Co Inc Papillomavirus vakzine
US5616595A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
JP3566461B2 (ja) 1996-06-28 2004-09-15 ユニ・チャーム株式会社 使い捨ての体液吸収性物品
US7122344B2 (en) * 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
DE19837391A1 (de) * 1997-08-22 1999-02-25 Hoffmann La Roche Immunologische Materialien und Verfahren zum Nachweis von Dihydropyrimidindehydrogenase
US6022477A (en) * 1997-11-14 2000-02-08 New Jersey Institute Of Technology Method and apparatus for isolation purification of biomolecules
US7820796B2 (en) 1998-03-12 2010-10-26 Genetics Institute, Llc. Methods for producing Factor VIII proteins
US6444223B1 (en) * 1999-05-28 2002-09-03 Alkermes Controlled Therapeutics, Inc. Method of producing submicron particles of a labile agent and use thereof
US6544424B1 (en) * 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US6350382B1 (en) * 2000-06-23 2002-02-26 Scilog, Inc. Enhancing filtration yields in tangential flow filtration
WO2003004690A2 (en) * 2001-07-06 2003-01-16 454$m(3) CORPORATION Method for isolation of independent, parallel chemical micro-reactions using a porous filter
DK1451290T3 (da) * 2001-08-31 2011-04-26 Bayer Schering Pharma Ag Indretning og fremgangsmåde til udførelse af fermentering af høj celledensitet
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US7078507B2 (en) * 2001-11-09 2006-07-18 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Synthetic genes for malarial proteins and methods of use
US20060172376A1 (en) * 2003-02-11 2006-08-03 Hassan Chadjaa Method and device for the continuous production of biomolecules
AU2003261387A1 (en) * 2003-02-24 2004-09-17 Gtc Biotherapeutics, Inc. Methods of tangential flow filtration and an apparatus therefore
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
PL1807101T3 (pl) 2004-09-30 2016-11-30 Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły

Also Published As

Publication number Publication date
EP1807101A4 (en) 2010-03-24
IL205228A0 (en) 2011-07-31
US20130344585A1 (en) 2013-12-26
KR101335936B1 (ko) 2013-12-03
IL217157A0 (en) 2012-01-31
IL217159A (en) 2015-04-30
US9133433B2 (en) 2015-09-15
RU2390526C2 (ru) 2010-05-27
NZ588616A (en) 2012-05-25
NO341439B1 (no) 2017-11-13
US9045725B2 (en) 2015-06-02
JP2008514237A (ja) 2008-05-08
NO20072174L (no) 2007-06-27
IL205228A (en) 2015-09-24
IL217157A (en) 2015-04-30
UA99249C2 (ru) 2012-08-10
US20080269468A1 (en) 2008-10-30
SI2550971T1 (sl) 2017-08-31
CN102794109A (zh) 2012-11-28
EP1807101A2 (en) 2007-07-18
HK1110519A1 (en) 2008-07-18
HRP20070097A2 (hr) 2008-11-30
RU2007115901A (ru) 2008-11-10
EP2550971B1 (en) 2016-11-09
PT2550971T (pt) 2017-10-02
CA2579845A1 (en) 2006-04-13
CY1117699T1 (el) 2017-05-17
JP5762360B2 (ja) 2015-08-12
HRP20070097B1 (hr) 2018-03-23
AU2005292358B2 (en) 2011-06-16
AU2005292358A1 (en) 2006-04-13
KR20070092949A (ko) 2007-09-14
DK2550971T3 (en) 2017-10-30
LT2550971T (lt) 2018-10-25
IL217158A0 (en) 2012-01-31
HUE032538T2 (en) 2017-10-30
IL181775A0 (en) 2007-07-04
NZ554307A (en) 2011-06-30
CN102794109B (zh) 2015-10-07
JP5579966B2 (ja) 2014-08-27
US20130345402A1 (en) 2013-12-26
CN101076347A (zh) 2007-11-21
HUE027136T2 (en) 2016-08-29
CN101076347B (zh) 2012-09-26
JP2012213772A (ja) 2012-11-08
ES2634323T3 (es) 2017-09-27
IL181775A (en) 2012-02-29
IL217158A (en) 2016-06-30
KR101238798B1 (ko) 2013-03-04
WO2006039588A2 (en) 2006-04-13
KR20130003025A (ko) 2013-01-08
CA2579845C (en) 2014-11-18
IL217159A0 (en) 2012-01-31
EP2550971A1 (en) 2013-01-30
UA107937C2 (en) 2015-03-10
ES2570006T3 (es) 2016-05-13
PL1807101T3 (pl) 2016-11-30
EP1807101B1 (en) 2016-04-13
WO2006039588A3 (en) 2007-05-18
NO20171138A1 (no) 2007-06-27
BRPI0515849B1 (pt) 2019-07-30
NO341885B1 (no) 2018-02-12
UA112529C2 (uk) 2016-09-26
DK1807101T3 (en) 2016-05-23
ZA200702578B (en) 2008-03-26

Similar Documents

Publication Publication Date Title
BRPI0515849A (pt) dispositivos e métodos para fabricação integrada contìnua de moléculas biológicas
Chollangi et al. Separation of proteins and lactose from dairy wastewater
BRPI0819580A2 (pt) Sistema de reator de membrana biológica de tratamento de água residual industrial, processo para purificar uma corrente de água residual industrial que contém compostos biologicamente refratários e/ou bio-inibidores e processo para tratar uma corrente de água residual industrial processada por um reator de membrana biológica
NO20091928L (no) Væskebehandlingsmetoder og apparatur
EP2107947A4 (en) SYSTEM AND METHOD FOR REMOVING SOLVENT CONTAMINATION, PARTICLE POLLUTION AND OIL POLLUTION FROM INDUSTRIAL WASTEWATER
WO2007076496A3 (en) Method and apparatus for the filtration of biological solutions
NZ600274A (en) Dialysis systems and methods
WO2009052102A3 (en) Solids removal system and method
MX378006B (es) Sistemas, metodos, procesos y aparatos para remover material en particulas finamente dispersada de una corriente de fluido.
WO2010125450A3 (en) Purifying device and method for elimination of xenobiotics in water
BR112016006469A2 (pt) sistema para separação de contaminantes de fluidos
ATE487525T1 (de) Durchflussentfernungsvorrichtung und solch eine vorrichtung verwendendes system
BR0308972A (pt) Processo para tratamento de águas residuais, para remover contaminantes decorrentes de processamento de animais
BR0318132A (pt) Processo para a purificação e a filtração de fluidos, notadamente de efluentes lìquidos tais como água bruta contendo poluentes orgânicos em solução e dispositivo para a execução do processo
WO2014152552A3 (en) Nanocomposite with nanochannels or nanopores for filtration of waste effluents
BRPI0512907A (pt) dispositivo de purificação, suplemento e método de purificação de um lìquido
MX372710B (es) Purificacion de agua contaminada con petroleo y dispositivo adecuado para la misma.
ATE553795T1 (de) Vorab ladbares flüssigkeits-filtrationsverfahren und gerät
BRPI0713374A2 (pt) sistema purificador de água, elemento de filtro para o sistema purificador de água, e, método para purificar água por meio de um sistema
EP3820815A4 (en) SYSTEM AND METHOD FOR SYNTHESIS OF GRAPHEN-ASSISTED PHOTOCATALYTIC NANOMATERIALS FOR AIR PURIFICATION
EP2221059A4 (en) COMPOSITION FOR REDUCING THE MIRROR OF GLUCOSE, MALONDIALDEHYDE-MODIFIED LDL, HOMOCYSTEIN AND / OR C-REACTIVE PROTEIN IN THE BLOOD
ATE395324T1 (de) Verfahren zur reinigung von dimethylacetamid (dmac)
WO2010065880A3 (en) Acetylene process gas purification methods and systems
TW200628228A (en) Apparatus for processing biochemical sample
RU2020107296A (ru) Удаление несвязанного лекарственного средства после связывания конъюгата антитело-лекарственное средство

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: BAYER HEALTHCARE LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/07/2019, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2847 DE 29-07-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.